For more than 100 years, RIVMNational Institute for Public Health and the Environment has been promoting public health and safeguarding a healthy and safe environment. We have a central role in infectious disease control, national prevention and population screening programmes and monitoring our population’s health and the state of our environment. We support citizens, professionals and national and local authorities in the challenge of keeping ourselves and our environment healthy, safe and sustainable. Our ambition is to be a trusted advisor using independent research as the basis for our advisory work. Below we present some of the global challenges we work on and elaborate on our tasks and international activities.
Highlighted themes
Climate change and health
Climate change and health
Food and Nutrition
Safe, healthy and sustainable food
Antibiotic resistance
Antimicrobial Resistance (AMR)
Population screening programmes
Population Screening programmes
Circular economy
Circular Economy
Immunisation and vaccination
Immunisation and vaccination
What we do
International collaboration
International collaboration
National tasks and activities
National tasks and activities
International projects and networks
International projects and networks
COVID-19 in the Netherlands
RIVMNational Institute for Public Health and the Environment advises the Dutch government on how to control the coronavirus as effectively as possible, monitors the COVID-19 outbreak and conducts research into SARS-CoV-2. RIVM is coordinating the implementation of the COVID-19 vaccinations in the Netherlands. Our institute is responsible for coordinating the storage and distribution of COVID-19 vaccines in the Netherlands (including the islands of Aruba, Bonaire, St Eustatius, Saba, Curaçao and St Maarten).
We provide weekly updates and data on COVID-19 in the Netherlands. In addition to our general COVID-19 weekly epidemiological update, we also publish a COVID-19 weekly update for the CAS and BES islands: the islands of Curaçao, Aruba and Sint Maarten and the special municipalities Bonaire, Sint Eustatius and Saba.
Would you like to be kept informed on our work and activities? Subscribe to our quarterly newsletter. Read our international newsletter issue 1, 2021.
News
People who had one jab after having COVID-19 now included in vaccination coverage figures for full vaccination
Vaccination coverage in the Netherlands rose more sharply this week than in previous weeks, increasing to 81.7% among people aged 18 years and older and 79.0% among those aged 12 years and older.
Vaccination figures now available by municipality
RIVM is providing access to COVID-19 vaccination figures by municipality via open data as of today. The open data now includes vaccination turnout and coverage by municipality for three age groups.
New international project Inno4Vac targets faster vaccine development
Inno4vac, a new European interdisciplinary project was launched on 1 September. Inno4vac focuses on the design and application of new and highly advanced predictive models to allow a faster development and manufacturing of new vaccines.
Vaccines very effective against hospital and ICU admissions, also for Delta variant
COVID-19 vaccines work well in preventing people from being admitted to hospital or ICU for COVID-19, according to a new analysis by RIVM.
COVID-19 vaccination reduces transmission
Vaccination against COVID-19 reduces the transmission of the virus from one person to another. This is apparent from RIVM research using data from source and contact tracing by the Municipal Public Health Services (GGDs).
Nearly 85% of people aged 18 and over have had at least one vaccination
The RIVM vaccination update this week has been expanded to include three maps of the Netherlands. For the first time, it is now possible to see vaccination turnout by municipality for everyone aged 18 years and over.
